ReGen Biologics, Incs common stock has been deleted from OTC Bulletin Board effective December 29, 2009 on account of failure to comply with NASD 6530. The company has been added other NBB.

ReGen Biologics Inc. entered into an Amended and Restated Subscription and Security Agreement, dated November 19, 2009, for the private placement of an aggregate principal amount of up to $3,000,000 of the Registrant's secured convertible notes. The Subscription Agreement amends and restates the Subscription and Security Agreement, dated October 2, 2009. Under the terms of the financing, the company received $450,000 in immediately available funds and aggregate commitments for $2,600,000, which includes $600,000 that has already been funded in October 2009, and issued $450,000 aggregate principal amount of the Notes. The Notes accrue interest at an annual rate of 8% until April 2, 2010 and 12% thereafter until paid, are secured by a first priority lien on all unencumbered assets of the company and a second priority lien on all encumbered assets of the company and are subject to a premium equal to 300% of the principal amount of the Notes then outstanding in the event the Registrant consummates certain fundamental transactions or repays the Notes without the consent of the Investors. After April 2, 2010, the investors may foreclose on the collateral securing the Notes.

Effective November 24, 2009, ReGen Biologics Inc. changed its OTCBB stock ticker symbol to RGBOE from RGBO.